Thompson CA, Yost K, Larson MC, et al. Changes in Quality of Life in Indolent Non-Hodgkin Lymphoma 3 Years after Diagnosis. ASH 59th Annual Meeting & Exhibition, abstract 917.
16 miljoen om in 3 jaar medicijn tegen myeloom te ontwikkelen
jun 2023 | MM